FindTrial
Sign In

EVALUATION OF EFFICACY OF POLYHERBAL GEL CONTAINING ASHWAGANDHA AND GINGER AS AN ADJUNCT TO PROFESSIONAL CLEANING IN GUM DISEASES

EVALUATION AND COMPARISON OF EFFICACY OF POLYHERBAL GEL CONTAINING ASHWAGANDHA AND GINGER AS AN ADJUNCT TO SCALING AND ROOT PLANING IN CHRONIC PERIODONTITIS â?? IN VIVO STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031486
Enrollment
23
Registered
2021-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: Polyherbal gel containing Ashwagandha and Ginger: Polyherbal gel will be placed intraorally into periodontal pockets of patients having Mild to Moderate Periodontitis as an adjunct to S

Sponsors

Dr Vishakha Padhye
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Minimum of 20 sound teeth to be present. Age â?? 25 to 55 years of either sex. Systemically healthy patients. Patients with chronic periodontitis (AAP 1999 Classification of periodontitis) having pocket probing depth > 4mm (preferably 4-7mm) in more than one quadrants. Patients who have not undergone any form of dental treatment (non-surgical or surgical periodontal therapy) in the last 6 months including oral prophylaxis.

Exclusion criteria

Exclusion criteria: Patients with history of antibiotics and non-steroidal anti-inflammatory drug use in the past 6 months. Pregnant women and lactating mothers. Smokers and patients consuming tobacco in any other form. Immuno-compromised patients. Patients who have history of any kind of allergy.

Design outcomes

Primary

MeasureTime frame
Assessment of Plaque Index (Silness J and Loe H, 1967), Sulcus Bleeding index (Muhlemann H.R and Son S, 1971), Periodontal Probing Depth, Clinical Attachment level, Alkaline Phosphatase levels present in Gingival Crevicular FluidTimepoint: Baseline, At 4th week (28 days)—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Shaila Kothiwale

KLE ACADEMY OF HIGHER EDUCATION AND RESEARCH

shailakothiwale2000@yahoo.co.in9448822706

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026